Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8453402 | Leukemia Research | 2018 | 6 Pages |
Abstract
In this retrospective analysis, RA and RARS/RARS-t patients receiving ICT had superior OS to non-ICT patients. These findings should be verified and other MDS subtypes examined in larger prospective analyses.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Shannon A. Wong, Heather A. Leitch,